Chantal Mathieu

机构：Universitair Ziekenhuis Leuven, KU Leuven · ORCID：0000-0002-6099-2406

发表论文 25 篇 · 总被引 739 次 · h-index 8

代表论文

• Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study (2018 · Diabetes Care · 被引 241)
• Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes (2025 · New England Journal of Medicine · 被引 134)
• Finerenone in Type 1 Diabetes and Chronic Kidney Disease (2026 · New England Journal of Medicine · 被引 27)
• The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum (2025 · Diabetologia · 被引 16)
• Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab (2025 · Diabetes Care · 被引 11)
• The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment—2024 Diabetes , Diabetes Care , and Diabetologia Expert Forum (2025 · Diabetes Care · 被引 11)